Skip to main content
. 2020 Aug 11;7:185. doi: 10.3389/fmolb.2020.00185

TABLE 2.

Oligonucleotides used in this work.

Construct Template Protein Sequence (5′ → 3′) Cloning technology
pOPINE-mobB pSU4814 MobBCloDF13 F: AGGAGATATACCATGTTTAATACGGATTCGCTTGCCTGGCAGTGG In-fusiona
R: GTGATGGTGATGTTTGTACAGCCCCGCAAAATCATCATCACCCG
pOPINE-MobBΔTMD pSU4814 MobBΔTMD F: AGGAGATATACCATGGACGAGGCGGTGAACGCGAAAC In-fusiona
R: GTGATGGTGATGTTTGTACAGCCCCGCAAAATCATCATCAC
pOPINE-3C-eGFP-mobB pSU4814 MobBCloDF13GFP F: AGGAGATATACCATGTTTAATACGGATTCGCTTGCCTGGCAGTGG In-fusiona
R: CAGAACTTCCAGTTTGTACAGCCCCGCAAAATCATCATCACCCG
pOPINE-3C-eGFP-MobBΔTMD pSU4814 MobBΔTMDGFP F: AGGAGATATACCATGGACGAGGCGGTGAACGCGAAAC In-fusiona
R: CAGAACTTCCAGTTTGTACAGCCCCGCAAAATCATCATCAC
pUBQ4 (K142T) pUBQ4 TMDTraJCDTrwB (K142T) F: AAGCAACACCGATGTACCCGTACCAGTGGCA Site-Directed mutagenesisb
R: GTGCCACTGGTACGGGTACATCGGTGTTGCTT
pUBQ4GFP pUBQ4 TMDTraJCDTrwBGFP F: CCGCTCGAGATGGACGATAGAGAAAGAGG Restriction enzymes (XhoI and BamHI)
R: CGCGGATCCGATAGTCCCCTCAAC

aBerrow et al. (2007). bQuikChange II Site-Directed Mutagenesis (Stratagene, San Diego, CA, United States).